Novo Holdings portfolio company Edgewise Therapeutics announces closing of IPO

Novo Holdings portfolio company Edgewise Therapeutics announces closing of IPO

Date
March 30, 2021

Novo Holdings would like to congratulate our portfolio company Edgewise Therapeutics, Inc., (NASDAQ: EWTX) on their recent IPO, a clinical-stage biopharmaceutical company focused on developing orally bioavailable, small molecule therapies for rare muscle disorders.

For further information, please find the full statement here.